Quality HTA is a consulting firm that provides evidence-based solutions for Health Technology Assessment, health economics, and outcomes research to support decision-makers in improving patient access and care.
Quality HTA is a healthcare consulting firm providing evidence-based solutions in Health Technology Assessment (HTA), Health Economics and Outcomes Research (HEOR), and Real-World Evidence (RWE). Founded by Pooyeh Graili, the firm integrates expertise in digital health, policy, and scientific research to help organizations understand the value of new medical interventions. They employ state-of-the-art methods to analyze clinical effectiveness, safety, and economic implications, supporting stakeholders throughout the lifecycle of pharmaceutical, biotechnology, and medical device products. Working with a diverse team of specialized collaborators, the company designs study methods, synthesizes evidence, and provides guidance for regulatory and reimbursement processes.
The firm serves a global clientele, including governments, hospitals, non-profits, and life-science organizations, helping them navigate complex decision-making challenges. By providing reliable evidence and customized insights, Quality HTA aims to accelerate patient access to innovative technologies and improve healthcare delivery. Their work is characterized by a commitment to rigorous scientific standards, transparency, and a focus on patient-centered outcomes, assisting partners in identifying relevant comparators and evaluating the feasibility of adopting new health technologies.